Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | PTPRC | P08575 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6011526 | 0.89 | CASP1 (0.44) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL5133404 | 0.87 | ALDH1A1 (0.65) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL6572102 | 0.84 | ALDH1A1 (0.48) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL6572324 | 0.84 | PDE10A (0.54) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL5688007 | 0.84 | TSHR (0.48) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL30075769 | 0.83 | TDP1 (0.50) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL2479814 | 0.83 | TDP1 (0.50) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL2010686 | 0.83 | CASP1 (0.34) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| Hydrochloric Acid SCHEMBL6571929 | 0.81 | TDP1 (0.48) | CASP1ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL6572927 | 0.81 | CYP3A4 (0.39) | CASP1ALDH1A1CYP3A4TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10639257-B2 | Composition for colouring keratin fibres | BEAUTY & BUSINESS S.P.A. (IT) | 2020-05-05 | — | — | US | claimed |
| US-20190117541-A1 | COMPOSITION FOR COLOURING KERATIN FIBRES | BEAUTY & BUSINESS S.P.A. (IT) | 2019-04-25 | — | — | US | claimed |
| EP-1051143-B1 | OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES | WELLA AG (DE) | 2004-07-21 | — | — | EP | claimed |
| US-11986547-B2 | Cosmetic composition comprising silicone materials | DOW SILICONES CORPORATION (US) | 2024-05-21 | — | — | US | disclosed |
| US-11820846-B2 | Composition, method of preparing copolymer, and methods and end uses thereof | DOW SILICONES CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| WO-2022256476-A1 | ORRIS ROOT EXTRACTS, COMPOSITIONS, AND METHODS FOR SKIN APPLICATIONS | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2022-12-08 | — | — | WO | disclosed |
| US-20220119421-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND RELATED COMPOSITIONS | DOW SILICONES CORPORATION | 2022-04-21 | — | — | US | disclosed |
| US-20220119597-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COPOLYMER FORMED THEREWITH | DOW TORAY CO., LTD. (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20220106337-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COMPOSITIONS COMPRISING SAME | DOW SILICONES CORPORATION | 2022-04-07 | — | — | US | disclosed |
| US-20220081565-A1 | ACRYLATE-FUNCTIONAL BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COPOLYMER FORMED THEREWITH | DOW SILICONES CORPORATION | 2022-03-17 | — | — | US | disclosed |
| EP-3906275-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COMPOSITIONS COMPRISING SAME | Dow Silicones Corporation (US) | 2021-11-10 | — | — | EP | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008107347-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
| EP-1408912-B1 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | DOW CORNING (US) | 2007-03-07 | — | — | EP | disclosed |
| EP-1051143-B1 | OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES | WELLA AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| EP-1408912-A2 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | Dow Corning Corporation (US) | 2004-04-21 | — | — | EP | disclosed |
| EP-1052252-B1 | Diaminobenzene derivatives and dyeing preparations containing them | WELLA AG (DE) | 2003-08-06 | — | — | EP | disclosed |
| WO-2003009819-A2 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | DOW CORNING CORPORATION (US) | 2003-02-06 | — | — | WO | disclosed |
| US-6500213-B1 | Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-31 | — | — | US | disclosed |
| US-6498197-B1 | Temperature insensitive one-phase microemulsions | DOW CORNING CORPORATION | 2002-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820846-B2 | Composition, method of preparing copolymer, and methods and end uses thereof | BRS3, OXSR1, OXER1 | CASP1 3569/4885ALDH1A1 3354/4885CYP3A4 1655/4885 |
| US-20220106337-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND COMPOSITIONS COMPRISING SAME | NR3C2, NR2E3, OXSR1 | CASP1 4284/4885ALDH1A1 4373/4885CYP3A4 2192/4885 |
| US-20220119421-A1 | BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND RELATED COMPOSITIONS | BRS3, NPSR1, NR3C2 | CASP1 4510/4885ALDH1A1 4384/4885CYP3A4 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.